Starlin H-Greatting,MS-MPH,BPharm,CDM,FAPhA,FADCES
@StarlinRPh
Followers
910
Following
13K
Media
478
Statuses
12K
Pharmacist: IPhA’s PSMP-Diabetes,DPP & CV Health.Pharmacist Driven Patient Centered Care!CMM-MTM;Pharmacoepidemiology/Healtheconomics
Springfield, Illinois
Joined July 2012
Some Missouri and Kansas pharmacists join effort to get drug prices under control
thebeaconnews.org
As health insurance costs soar, lowering prescription prices could help. But that will require reforms in Jefferson City and Topeka.
0
0
0
Disordered eating is often invisible in people with diabetes—affecting all ages, genders & sizes. “Eating disorders don’t have a look,” says ADCES Spokesperson Janice Baker, MBA, RDN, CDCES, CNSC, BC-ADM. DCES & HCPs play a vital role in support. Swipe for tips! #DiabetesCare
0
1
1
Listen in as ADCES President Veronica Brady talks about implicit bias, the focus of an #ADCES25 workshop, general session panel, and spoken word performance by Kondwani Fidel.
1
1
4
2026 ADCES President Katherine O'Neal and the Ohio CB are gearing up to host you in Columbus for #ADCES26!
0
2
2
We hope you enjoyed #ADCES25! Claim your CE at https://t.co/YfF9oML21n and watch your inbox for details on how to access on-demand sessions. We'll see you at #ADCES26 in Columbus Friday, August 7 - Monday, August 10.
0
1
3
Don't forget to claim your #ADCES25 CE! All evaluations can be completed online. Look for an email in your inbox or visit https://t.co/RedvIqHLd6.
0
1
1
Our Showcase the Value of Your DSMES Services Toolkit received a Power of Associations Silver Award! This members-only toolkit provides tips and resources to help demonstrate the #value DCES bring to people with #diabetes. https://t.co/o6p0kDjZ4a
0
1
1
0
1
1
In older adults with T2D, SGLT2i use was associated with a lower risk of nephrolithiasis compared to DPP4i, particularly among men, non-Hispanic Black individuals, and those without baseline nephrolithiasis. https://t.co/AlOPGEW8aR
0
3
5
According to the World Health Organization, over 650 million adults worldwide are fighting obesity. So remember: You're not alone! Check out The AACE Journey for Patients With Obesity for medically-accurate information & guidance: https://t.co/wG8keoclcd
#endocrinology
1
4
4
Meta-analysis of GLP-1RAs and gastrointestinal adverse events. GLP-1RAs are associated with an increased risk of cholelithiasis and GERD, but do not appear to increase the risk of other gastrointestinal or biliary adverse events. https://t.co/gyZK9vZsuP
4
72
257
0
1
1
💉 GLP-1 meds don’t just curb appetite—sometimes they curb essential nutrients too. - - - 📉 In a study of 460,000+ adults on GLP-1s (mostly with T2D): 🔹13% developed nutritional deficiencies in 6 months 🔹22% within 12 months 🔹Vitamin D deficiency was most common (13.6%) 🔹3%
6
51
141
Who benefits from over-the-counter CGMs? https://t.co/dcnQBA7SiO via @MedTechDive
medtechdive.com
Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for adults without diabetes.
1
1
2
Exciting about the Sequel Twiist new insulin pump working with @Tidepool_org! See article in @GoHealio with my Perspective.
healio.com
The FDA granted 510(k) clearance for an automated insulin delivery system that can measure the volume and flow of insulin within every micro-dose, according to an industry press release. The twiist...
0
3
11
Have you check this out! @TheAACE
Whether you're newly diagnosed with diabetes or have had it for years, understanding your diabetes technology options can feel overwhelming. The AACE Journey of Diabetes Technology is a patient friendly guide to the devices that can help you manage your blood sugar. Learn more:
0
2
9
Thrilled to announce the release of the new @ADA_DiabetesPro Consensus Statement: #MASLD is now recognized as a major metabolic complication in type 2 diabetes and obesity, underscoring the central role of insulin resistance and cardiometabolic risk factors in its pathogenesis.
7
68
176
Orforglipron is being tested in a dedicated trial for #Hypertension Will the results change how we approach BP management?
ahajournals.org
In the management of hypertension, only limited advances have been made over the past decades. Recent studies highlight the potential of next-generation incretin-based therapeutics, such as GLP-1 RAs...
1
17
49
Debate Fri 6.20 1245pm at #ADASciSessions OTC CGM: Data 4 all or a disaster waiting to happen. @AhnCall prepare to be taken down! #CGM4all
1
2
14